206 related articles for article (PubMed ID: 32614605)
1.
Liu Y; Li Y; Wang X; Huang Y; Zhang Q; Shi K; Ran C; Hou J; Wang X
J Altern Complement Med; 2020 Oct; 26(10):956-965. PubMed ID: 32614605
[No Abstract] [Full Text] [Related]
2. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
3. Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis.
Jeong SW; Jang JY; Shim KY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim KH; Kim JH
Gut Liver; 2013 Nov; 7(6):696-703. PubMed ID: 24312711
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
5. Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors.
Jiao T; Tang H; Zhang W; Hu B; Wan T; Cao Y; Zhang Z; Wang Y; Cao J; Cui M; Lu S
BMC Surg; 2023 Dec; 23(1):384. PubMed ID: 38114938
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis.
Gao Y; Wang PX; Cheng JW; Sun YF; Hu B; Guo W; Zhou KQ; Yin Y; Li YC; Wang J; Huang JF; Qiu SJ; Zhou J; Fan J; Yang XR
Cancer Med; 2019 Nov; 8(16):6933-6944. PubMed ID: 31566899
[TBL] [Abstract][Full Text] [Related]
7. Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study.
Yuan J; Yin X; Tang B; Ma H; Zhang L; Li L; Chen R; Xie X; Ren Z
Biomed Res Int; 2019; 2019():2141859. PubMed ID: 31467872
[TBL] [Abstract][Full Text] [Related]
8. Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study.
Kawai T; Yashima Y; Sugimoto T; Sato T; Kanda M; Enomoto N; Sato S; Obi S
World J Surg Oncol; 2016 Feb; 14():52. PubMed ID: 26911980
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of preoperative circulating tumor cells for hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score analysis.
Yu JJ; Li YN; Shu C; Yang HY; Huang Z; Tao R; Chen YY; Chen XP; Xiao W
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8981-8991. PubMed ID: 37160624
[TBL] [Abstract][Full Text] [Related]
10. The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study.
Mähringer-Kunz A; Steinle V; Kloeckner R; Schotten S; Hahn F; Schmidtmann I; Hinrichs JB; Düber C; Galle PR; Lang H; Weinmann A
PLoS One; 2021; 16(5):e0249426. PubMed ID: 33961627
[TBL] [Abstract][Full Text] [Related]
11. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
Mähringer-Kunz A; Steinle V; Düber C; Weinmann A; Koch S; Schmidtmann I; Schotten S; Hinrichs JB; Graafen D; Pinto Dos Santos D; Galle PR; Kloeckner R
Liver Int; 2019 Feb; 39(2):324-331. PubMed ID: 30318826
[TBL] [Abstract][Full Text] [Related]
12. Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: a matched nested case-control study.
Lim J; Kim HI; Kim E; Kim J; An J; Chang S; Kim SO; Lee HC; Lee YS; Shim JH
BMC Cancer; 2021 Jan; 21(1):11. PubMed ID: 33402105
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
14. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review.
Tao ZW; Cheng BQ; Zhou T; Gao YJ
Hepatobiliary Pancreat Dis Int; 2022 Apr; 21(2):134-144. PubMed ID: 34955380
[TBL] [Abstract][Full Text] [Related]
15. Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi-institutional propensity-matched cohort study.
Komatsu S; Ueshima K; Kido M; Kuramitsu K; Tsugawa D; Yanagimoto H; Toyama H; Ku Y; Kudo M; Fukumoto T
J Hepatobiliary Pancreat Sci; 2023 Mar; 30(3):303-314. PubMed ID: 36047804
[TBL] [Abstract][Full Text] [Related]
16. TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension.
Qiu Z; Wang G; Yan H; Qi H; Zuo M; Wang G; Jiang W; Chen Z; Xue J; Lu L; Zhang F; Gao F
Eur Radiol; 2022 Oct; 32(10):6777-6787. PubMed ID: 35441840
[TBL] [Abstract][Full Text] [Related]
17. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.
Liu X; Li M; Wang X; Dang Z; Yu L; Wang X; Jiang Y; Yang Z
Phytomedicine; 2019 Sep; 62():152930. PubMed ID: 31128485
[TBL] [Abstract][Full Text] [Related]
18. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Choi JH; Chung WJ; Bae SH; Song DS; Song MJ; Kim YS; Yim HJ; Jung YK; Suh SJ; Park JY; Kim DY; Kim SU; Cho SB
Cancer Chemother Pharmacol; 2018 Sep; 82(3):469-478. PubMed ID: 29982870
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram.
Li X; Ye Z; Lin S; Pang H
BMC Cancer; 2021 Jun; 21(1):701. PubMed ID: 34126955
[TBL] [Abstract][Full Text] [Related]
20. Nomogram for Individualized Prediction of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis on Conservative Treatment.
Liu Y; Xue D; Zhang X; Gao F; Sun L; Yang X; Li Y; Zhang Q; Zhu B; Niu S; Huang Y; Hu Y; Wang X
Biomed Res Int; 2020; 2020():1473718. PubMed ID: 32149077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
